PL3930686T3 - Nowatorskie kompozycje żelaza oraz sposoby ich wytwarzania i stosowania - Google Patents

Nowatorskie kompozycje żelaza oraz sposoby ich wytwarzania i stosowania

Info

Publication number
PL3930686T3
PL3930686T3 PL20717359.2T PL20717359T PL3930686T3 PL 3930686 T3 PL3930686 T3 PL 3930686T3 PL 20717359 T PL20717359 T PL 20717359T PL 3930686 T3 PL3930686 T3 PL 3930686T3
Authority
PL
Poland
Prior art keywords
making
methods
same
novel iron
iron compositions
Prior art date
Application number
PL20717359.2T
Other languages
English (en)
Inventor
Donald Jeffrey Keyser
Alvaro F. Guillem
Richard A. ZAGER
Original Assignee
Renibus Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renibus Therapeutics, Inc. filed Critical Renibus Therapeutics, Inc.
Publication of PL3930686T3 publication Critical patent/PL3930686T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL20717359.2T 2019-02-28 2020-02-28 Nowatorskie kompozycje żelaza oraz sposoby ich wytwarzania i stosowania PL3930686T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962812028P 2019-02-28 2019-02-28
PCT/US2020/020517 WO2020176894A1 (en) 2019-02-28 2020-02-28 Novel iron compositions and methods of making and using the same

Publications (1)

Publication Number Publication Date
PL3930686T3 true PL3930686T3 (pl) 2023-11-27

Family

ID=70190086

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20717359.2T PL3930686T3 (pl) 2019-02-28 2020-02-28 Nowatorskie kompozycje żelaza oraz sposoby ich wytwarzania i stosowania

Country Status (20)

Country Link
US (4) US11292813B2 (pl)
EP (2) EP3930686B1 (pl)
JP (3) JP7320611B2 (pl)
KR (1) KR102997223B1 (pl)
CN (2) CN113825496B (pl)
AU (2) AU2020229381A1 (pl)
CA (1) CA3131596A1 (pl)
DK (1) DK3930686T3 (pl)
ES (1) ES2955019T3 (pl)
FI (1) FI3930686T3 (pl)
HR (1) HRP20230989T1 (pl)
HU (1) HUE063182T2 (pl)
LT (1) LT3930686T (pl)
PL (1) PL3930686T3 (pl)
PT (1) PT3930686T (pl)
RS (1) RS64652B1 (pl)
SG (1) SG11202109323UA (pl)
SI (1) SI3930686T1 (pl)
SM (1) SMT202300276T1 (pl)
WO (1) WO2020176894A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022056378A1 (en) * 2020-09-11 2022-03-17 Renibus Therapeutics, Inc. Method for treating cancer with kidney protection
JP2024534172A (ja) * 2021-08-27 2024-09-18 ヴァイフォー（インターナショナル）アーゲー 鉄組成物並びにそれらを作製及び使用する方法
WO2024069644A1 (en) * 2022-09-30 2024-04-04 West Bengal Chemical Industries Limited A pharmaceutically acceptable ferric carboxymaltose and preparation thereof
CN115969714B (zh) * 2022-11-03 2025-03-11 华熙生物科技股份有限公司 具有光谱选择性的防晒组合物及其应用
EP4772557A1 (en) 2023-08-29 2026-07-08 Daicel Corporation Curable epoxy composition

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE862482C (de) * 1950-05-14 1953-01-12 Merck Chem Fab E Verfahren zur Darstellung haltbarer, injizierbarer Loesungen von Salzen des dreiwertigen Eisens
US5624668A (en) 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations
DE19547356A1 (de) 1995-12-19 1997-06-26 Vifor Int Ag Adsorbens für Phosphat aus wäßrigem Medium, dessen Herstellung und Verwendung
US20030232738A1 (en) * 1998-04-20 2003-12-18 National Jewish Medical And Research Center Method and composition for increasing CD4+ T lymphocyte immune responsiveness
CA2365787C (en) * 2000-12-20 2006-02-14 Dialysis Solutions Inc. Sterile low bicarbonate dialysis concentrate solutions
DE60229303D1 (de) * 2002-08-26 2008-11-20 Vifor Int Ag Bioäquivalenztest für eisenhaltige formulierungen
WO2005094202A2 (en) * 2004-03-16 2005-10-13 Navinta, Llc Iron sucrose complexes and method of manufacture thereof
WO2006061685A1 (en) 2004-12-06 2006-06-15 Emcure Pharmaceuticals Limited A cost-effective process for preparation of manufacture of iron sucrose
ITMO20050056A1 (it) 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
CN100528237C (zh) 2005-04-26 2009-08-19 重庆医药工业研究院有限责任公司 多核的氢氧化铁-糖复合物的制备方法
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
EP2992886A1 (en) 2006-10-04 2016-03-09 InfaCare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
EP1947120A1 (de) 2007-01-19 2008-07-23 Vifor (International) Ag Eisen-Kohlenhydrat-Komplex-Verbindungen
IN269965B (pl) 2007-06-25 2015-11-27 Claris Lifescienses Ltd
TWI592159B (zh) 2007-11-16 2017-07-21 威佛（國際）股份有限公司 藥學組成物
CN102341111A (zh) 2009-03-02 2012-02-01 维福（国际）股份公司 磷酸盐吸附剂
CN106176808A (zh) * 2010-10-19 2016-12-07 长春纳米生技公司 金属离子纳米簇组合物
EP2548562A1 (de) 2011-07-18 2013-01-23 SeBo GmbH Kombinationstherapie mit Eisen-basierenden Phosphatadsorbern
EP2647389A1 (en) * 2012-04-04 2013-10-09 Charité - Universitätsmedizin Berlin Magnetic nanoparticle dispersion, its preparation and diagnostic and therapeutic use
CN103340827B (zh) * 2013-07-16 2014-12-10 成都天台山制药有限公司 蔗糖铁注射液及其制法
CN104558064A (zh) * 2013-10-29 2015-04-29 北京京卫信康医药科技发展有限公司 蔗糖铁的制备方法
IN2013CH05383A (pl) 2013-11-21 2015-08-28 Reddy’S Lab Ltd Dr
CN104098616B (zh) 2014-05-27 2016-04-20 广西壮族自治区化工研究院 一种蔗糖铁的制备方法
AU2015324103C1 (en) * 2014-09-29 2020-08-20 Fred Hutchinson Cancer Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
US20190106454A1 (en) * 2016-03-23 2019-04-11 Fred Hutchinson Cancer Research Center Compounds linked with a saccharide metal complex and uses thereof
WO2018148217A1 (en) * 2017-02-08 2018-08-16 Fred Hutchinson Cancer Research Center Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers
SG11202001594TA (en) 2017-09-11 2020-03-30 Pharmacosmos Holding As Iron complex compounds for therapeutic use
CN109912675B (zh) 2017-12-13 2020-09-15 北京市林业果树科学研究院 一种蔗糖亚铁及其制备方法
CN110063965A (zh) 2019-06-04 2019-07-30 吉林省富生医疗器械有限公司 一种血液透析浓缩物
CN112315902B (zh) 2019-08-05 2022-05-13 南京恒生制药有限公司 一种低易变铁含量蔗糖铁注射液制备方法
WO2022072439A1 (en) 2020-09-29 2022-04-07 Lg Bionano Co. Ltd Methods of preparing iron complexes
CN112168844A (zh) 2020-09-29 2021-01-05 神奈纳米医药技术(珠海)有限公司 一种氢氧化铁碳水化合物复合物的制备方法
CN112156109A (zh) 2020-09-29 2021-01-01 神奈纳米医药技术(珠海)有限公司 氢氧化铁-糖络合物的制备方法及其应用
CN115531414A (zh) 2021-06-30 2022-12-30 南京恒生制药有限公司 一种新型蔗糖铁复合物及其制备方法
JP2024534172A (ja) 2021-08-27 2024-09-18 ヴァイフォー（インターナショナル）アーゲー 鉄組成物並びにそれらを作製及び使用する方法

Also Published As

Publication number Publication date
HRP20230989T1 (hr) 2023-12-08
HUE063182T2 (hu) 2024-01-28
US11834471B2 (en) 2023-12-05
EP4234020A3 (en) 2023-10-04
US20230070012A1 (en) 2023-03-09
EP4234020A2 (en) 2023-08-30
WO2020176894A1 (en) 2020-09-03
PT3930686T (pt) 2023-09-04
JP2025084949A (ja) 2025-06-03
KR102997223B1 (ko) 2026-07-29
CN119488480A (zh) 2025-02-21
DK3930686T3 (da) 2023-09-11
US20240002427A1 (en) 2024-01-04
SI3930686T1 (sl) 2023-11-30
LT3930686T (lt) 2023-10-10
US11292813B2 (en) 2022-04-05
CN113825496A (zh) 2021-12-21
EP3930686B1 (en) 2023-05-31
US20220242901A1 (en) 2022-08-04
SMT202300276T1 (it) 2023-11-13
FI3930686T3 (fi) 2023-09-01
EP3930686A1 (en) 2022-01-05
CN113825496B (zh) 2024-09-27
JP2023139154A (ja) 2023-10-03
AU2020229381A1 (en) 2021-09-16
JP7320611B2 (ja) 2023-08-03
KR20210133243A (ko) 2021-11-05
JP2022522009A (ja) 2022-04-13
RS64652B1 (sr) 2023-10-31
AU2025230678A1 (en) 2025-10-02
US11840552B2 (en) 2023-12-12
SG11202109323UA (en) 2021-09-29
US20200277325A1 (en) 2020-09-03
CA3131596A1 (en) 2020-09-03
ES2955019T3 (es) 2023-11-28
JP7646750B2 (ja) 2025-03-17

Similar Documents

Publication Publication Date Title
GB2597163B (en) Cannabinoid compositions and methods of using
SG11202106521QA (en) Carbonate aggregate compositions and methods of making and using the same
IL280134A (en) Anti-CD112R preparations and methods
SMT202300276T1 (it) Nuove composizioni a base di ferro e metodi di realizzazione e uso delle stesse
SG11202101777VA (en) Methods and compositions for the modification of plants
GB202017593D0 (en) Compositions and methods and uses relating thereto
GB2578519B (en) Compositions and methods and uses relating thereto
IL290331A (en) RNA-directing ligands, preparations containing them, and methods for their preparation and use
SG11202104448WA (en) Compositions and methods
IL290325A (en) Biopharmaceutical preparations and related methods
GB201817444D0 (en) Methods and compositions
GB202010955D0 (en) Fruit and vegtable-based fermentate compositions and methods of making and using the same
GB201815402D0 (en) Compositions and methods and uses relating thereto
GB201905386D0 (en) Probiotic compositions and uses thereof
GB201909298D0 (en) Novel compositions and uses thereof
GB201819987D0 (en) Methods and compositions
IL287316A (en) compounds and preparations
SI4027976T1 (sl) Sestavki rifabutina in postopek izdelave
GB201804092D0 (en) Methods and compositions
GB201919385D0 (en) Compositions and methods of manufacture
SG11202108262VA (en) Bacterialcidal methods and compositions
GB201901413D0 (en) Compositions and their use
GB2586313B (en) Compositions and methods and uses relating thereto
GB201917066D0 (en) Methods and compositions
GB201907351D0 (en) Compositions and uses thereof